Cyclacel Pharmaceuticals Inc (CYCC) — Cash Flow Reinvestment Rate
Latest as of December 2009:
0.00x
Cyclacel Pharmaceuticals Inc (CYCC) has a Cash Flow Reinvestment Rate of 0.00x as of December 2009, reinvesting $2.00K (capex $2.00K ) from operating cash flow of $12.62 Million. Explore reinvestment intensity of Cyclacel Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$2.00K
Capex + Investments
Operating Cash Flow
$12.62 Million
USD
Capital Expenditures
$2.00K
USD
Annual Cash Flow Reinvestment Rate for Cyclacel Pharmaceuticals Inc (None–None)
Year-by-year capital reinvestment analysis for Cyclacel Pharmaceuticals Inc. For live market cap and broader valuation context, see Cyclacel Pharmaceuticals Inc (CYCC) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow